The Effects of Mepacrine Hydrochloride (Atabrine) Upon the Human Skin  by Miller, Otis B. et al.
THE EFFECTS OF MEPACRINE HYDROCHLORIDE (ATABRINE)
UPON THE HUMAN SKIN*
OTIS B. MILLER, M.D., FRANZ HERRMANN, M.D. AND J. RUBIN, M.D.
In recent years Mepacrine Hydrochloride (Atabrine) has been one of the most
widely used of all drugs. It has been administered to millions of persons for the
prevention and/or treatment of malaria. In the course of its employment, vari-
ous skin effects have been noted, or have been assumed to take place. Among
these cutaneous effects (1) (2) are: yellowish discoloration, lichenoid and other
dermatoses and photosensitization, respectively increased resistance to the effects
of light.
The present studies of the effects of Atabrine upon the human skin are experi-
mental in nature and can be divided into three parts:
I. Investigations of the Skin's Sensitivity to Ultraviolet Radiation.
II. Studies of the Skin's Color and Fluorescence, and of its Sweat Delivery.
III. Studies under the Microscope, both of the Skin's Surface and of Biopsy
Sections.
PART I
The skin of volunteers was subjected to measured quantities of ultraviolet
rays before and after administration of Atabrine. No evidence of sensitization
to the rays and no evidence of reduction of sensitivity was demonstrable in three
volunteers, either during, or after ingestion of Atabrine, .09 Gm daily, over a
period of at least one month.
PART II
The effect of Atabrine ingestion on the color, fluorescence and sweat function
of the skin was studied in seven human subjects. Four of these subjects were
healthy, young, male volunteers, and three were patients suffering from cuta-
neous diseases. The four healthy volunteers took .09 Gm daily for at least four
weeks; the three patients received much larger doses, namely .09 Gm from three
to four times daily. The findings in both the healthy volunteers and the patients
were similar except that they were more pronounced in the patients who received
the larger doses. The results can be summarized as follows:
a) Skin color in ordinary light. A very transitory and mild jaundice-like dis-
coloration of the skin was noticed on one of the volunteers as early as two weeks
after he started to take the drug. The discoloration disappeared at the end of the
third week, despite continued ingestion of the drug, and did not recur after ad-
ministration of the drug was discontinued.
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b) Examination in filtered ultraviolet irradiation (3100 A—4100 A).'
1. Su7 face of Skin and Nails. A very distinct, greenish-yellow fluorescence was
apparent not only in the nails, but also in the entire skin and the mucous mem-
branes of all the test subjects. This observation is in full agreement with the
findings of K. Lange and M. J. Matzner (3), but it is at variance with those of
the other investigators (4) (5).
In the volunteers who took .09 Gm daily, the fluorescence appeared within five
days after beginning the administration of Atabrine, increased during the sub-
sequent weeks (see Fig. 1), and even continued to increase for two weeks after
discontinuation of the drug. The intensity of fluorescence persisted at a maxi-
mum for about two more weeks, i.e. until four weeks after discontinuation of the
FIG. 1. Fluorescence of Palm, one month after Beginning of Atabrine Intake (.09 Gm
daily); Palm A (on right side) from Test Subject; B (on left side) from Control Subject.
drug. Thereafter, the fluorescence declined, but did so extremely slowiy, so that
a jade-like color was still noticeable all over the body eight weeks after the ter-
mination of drug ingestion. The persistence of fluorescence was particularly
noteworthy on the palms and soles. In one case residual fluorescence of the soles
was noted as late as fourteen weeks after cessation of Atabrine administration.
As far as intensity is concerned, the strongest fluorescence was regularly seen
on the arch of the soles, and the next strongest on the distal phalanges of the
fingers, on the palms, and in the axillary vaults.
Simultaneously with the diffuse fluorescence, many strongly fluorescent points
1The source of radiation was a spot type mercury vapor reflector bulb, supplied by G. W.
Gates and Co., Long Island City, N. Y.
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of about pinhead size were present on almost the entire skin surface, especially
on trunk and extremities (see Fig. 2).
The significance of all these findings was ascertained by careful comparison
with the appearance of the skin in control subjects not taking any drug, who
failed to show equivalent changes.
A peculiar pattern of transverse, fluorescent bands was observed in all the
nail-plates four weeks after the end of the drug ingestion and this continued
through the subsequent months. The appearance of new fluorescent bands at the
matrix of the toe nails, coincided with a periodic appearance of fluorescence on
the soles during this late phase.
FIG. 2. "Pinhead Fluorescence" on Back, one Month after Beginning of Atabrine In-
take (.09 Gm daily).
2. Specimens Taken from the Skin and Its Appendages. Various types of speci-
mens were collected from the skin and examined for fluorescence under filtered
ultraviolet radiation. Of these specimens, the coating of the hair-roots from the
trunk, axillae, and extremities, the follicular plugs from the same areas, scrapings
from the skin of the soles, and the ether-soluble material in pooled samples from
the entire skin surface, carried almost all the fluorescent material, whereas the
sweat showed only very occasional traces of fluorescence. In conformity with our
other observations, the fluorescence was still present in specimens taken from
the skin a remarkably long time after cessation of the ingestion of Atabrine; e.g.
the follicujar plugs and the coats of the hair roots fluoresced when removed as late
as twelve weeks, and the scrapings from the soles fluoresced as late as 15 weeks
after the last dose of Atabrine was taken.
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These assays left no doubt that the skin plays a significant role in the elimina-
tion of Atabrine from the body.
In spite of the minute and rare traces of fluorescent material found by us in the
native sweat, we believe that some participation of the sudoriferous system in
the process of elimination of Atabrine through the skin is probable. We are
inclined to this opinion because of the fact that the sites of maximal fluorescence
are precisely those of maximal sweating, and because of other biochemical and
electrochemical considerations which will not be detailed here.
c) Atabrine Dermatitis. A lichenoid dermatitis appeared in one of the volun-
teers after he had been taking .09 Gm of Atabrine daily for four weeks. This
eruption occurred despite the fact that no increased sensitivity to ultraviolet
rays could be demonstrated by quantitative exposures to the Mercury Vapor
Lamp.
During the eruption this volunteer was exposed to dry heat and careful quanti-
tative estimations were made of the sweat delivery of his skin. It was found that
outpouring of sweat was radically diminished at the sites involved by the der-
matitis.
This observation brings support to Sulzberger's hypothesis of the pathogenetic
role of sweat retention and autogenous intracutaneous injection of Atabrine in
lichenoid Atabrine dermatitis (6); and fits in well with the observations of Liv-
ingood et al. (7). The reduction of sweat delivery can perhaps, best be explained
on the basis of the experimental, histopathologic, and clinical findings obtained
previously by Sulzberger et al. (8) (9).
d) Sweat Delivery. In one of the volunteers, the quantity of sweat delivered
in various skin sites was studied under standardized experimental conditions,
and at regular intervals. The measurements were made before, during, and for
a long time after the ingestion of Atabrine. During the first two weeks after
beginning of administration of the drug, the delivery of measurable quantities
of sweat on the trunk required twice as long an exposure to environmental heat
as that which is ordinarily needed. Furthermore, the amount of sweat delivered
on the trunk was less than half that of the average which occurs under the same
conditions in subjects not taking Atabrine. However, four weeks after discon-
tinuation of the drug, the sweat delivery in this volunteer began slowly to revert
toward normal, but regained its original and normal values only two and one
half months after the drug had been stopped. This observation fits in with the
hypothesis that the drug antagonizes the outward movement of sweat in the
duct by decreasing the electrophysiologic negativity at the distal end of the
sweat ducts, and thus reducing the physiologic potential along the ducts (9).
PART III
Vital staining effects after ingestion, and after external application of Atabrine
(these were observed microscopically in the same seven subjects used in the
previous studies) 2
'Details of the technics employed will be described in a separate communication. We
are indebted to Dr. D. L. Milberg for taking the photomicrographs, with a technic which
he recently described (11).
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a) Examination (through the stereoscopic wide field microscope) in situ after
Atabrine ingestion: Examination of the skin (covered with Schillaber's oil) in
situ, under filtered ultraviolet radiation, showed a selective, canary-yellow flu-
orescence of the spiral portion of the sweat ducts and their orifices (see Fig. 3).
This fluorescence increased gradually during the period of ingestion of the drug,
and even continued to increase for some time—about two weeks—after adminis-
tration of the drug was discontinued. Somewhat later, the fluorescence gradually
declined towards normal. Some spirals distinctly exceeded others in intensity
of their fluorescence.
The follicles at the root sheaths of the hair showed fluorescent material (see
Fig. 4). The fluorescence was stronger at the roots of the lanugo hairs than of the
FIG. 3. Fluorescence of Sweat Ducts Three Weeks after Discontinuation of Atabrine
(.09 Gm daily for one Month).
other hairs. The fluorescence increased more slowly, and persisted for a consid-
erably longer period of time at the root sheaths of the hair than at the terminal
portion of the sweat ducts.
In a patient who had suffered for the last six years from an increasingly severe
'sweat retention syndrome," which was the consequence of degenerative altera-
tions following lichenoid Atabrine dermatitis, and who had lost a great number
of his sweat ducts through atrophy [previously reported (8)1, the remaining
sweat ducts differed very much in appearance from those in healthy subjects.
Uniformity was lacking in the pattern of the sweat duct spirals, both in regard
to the distribution and the size of the visible remnants. Under filtered radiation
many of the oversized, as well as of the smaller ducts, appeared intensely bluish-
white. This form of fluorescence (which is ordinarily not seen) suggested that
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traces of the drug were still being retained by the lining of the terminal portion
of those ducts as long as six years after the last known ingestion of Atabrine.
b) Examination of histologic sections of skin after Atabrine ingestion: Histologic
sections of biopsy specimens from two persons taking Atabrine by mouth, were
examined in the beam of filtered ultraviolet rays. A greenish fluorescence was
distinctly visible in the same structures which had been found to fluoresce when
the skin was examined in situ. In addition, the stratum corneum was intensely
fluorescent.
Due to the fluorescence of the horny layer, the fluorescent spiral parts of the
sweat ducts had the appearance of invaginated downward extensions of the
stratum corneum.
FIG. 4. Fluorescence of Follicles Three Weeks after Discontinuation of Atabrine (.09
Gm daily for one Month).
c) Examination in situ after external application of Atabrine: External appli-
cation of Atabrine (0.05%) in water to the skin surface produced intense fluores-
cence of the ostia and the spiral portions of the sweat ducts in situ. (Prior to the
examination any excess of applied material remaining on the skin after drying
was removed with a moistened swab.)
In these local applications, Atabrine showed itself to be capable of bringing
about a more distinctive pattern of fluorescence than any of the dyes employed
topically in our previously reported experiments (9).
In correlation with the observations described in part II, the implications of
the presented microscopic findings may be summarized as follows:
1. The selective fluorescent staining of the spiral ducts could be demonstrated
by all methods of investigation employed by us, i.e. oral administration, local
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application and both in. vivo and histopathologic examinations. These findings
lend further support to the previously reported concept that the terminal part
of the sweat ducts is characterized by electrophysiologic negativity.
2. In this recently advanced hypothesis, under normal conditions the electro-
physiologic potential of the sweat duct is presumed to facilitate the outflow of
sweat by electrophoresis. A positively charged drug, in the present studies Ata-
brine,3 would be attracted to the terminal end of the ducts, thus decrease the
electronegativity of these segments, and thereby reduce the presumptive electro-
physiologic potential along the ducts. This would serve to explain the inhibition
of sweat delivery caused by ingestion of Atabrine.
3. According to previously outlined conceptions (6) (8), excessive retention
of sweat under such an influence of Atabrine may result in a clinical equivalent
of miliaria, and consequent leakage or injection of Atabrine-containing sweat into
the epidermis and/or cutis. This in turn may cause the drug to come in contact
with structures which develop an allergic sensitization, and thus may produce
an allergic dermatitis. The greatly reduced outpouring of sweat in lichenoid
Atabrine dermatitis fits in with, but does not prove this hypothesis.
4. The microscopic findings in the skin of the patient with lasting sequelae of
Atabrine dermatitis, in particular the hypertrophy and the persistent fluores-
cence of a considerable number of the remaining spirals, are suggestive of com-
pensatory alterations and compensatory hypertrophy to make up for the loss of
a great number of sweat ducts destroyed by degeneration.
5. The histologic appearance of the end portion of the sweat ducts, and the
identical staining characteristics of these structures and the stratum corneum
suggest that the lining of the spiral part of the ducts consists of keratin, or of
material closely related to keratin. Most recently, and on morphologic grounds,
O'Brien arrived at the same conclusion (10).
In previously reported studies and in those of the present report there has
come to light a consistently uniform behavior on the part of the sweat duct
spirals and of the structures known to consist of keratin. This suggests that all
these structures have in common not only their physiologic electronegativity,
but also share interdependent biologic functions and form parts of a complex
functioning unit or system.
REFERENCES
1. SULZBERGER, MARION B., AND BAER, R. L.: a): Skin Tests and Other Immunologic
Procedures in Common Dermatologic and Venereal Conditions; Part III, Drug Erup-
tions (iDermatitis Medicamentosa: Toxidermas Due to Drugs). Year Book of Dermat.
& Syph., The Year Book Publishers Inc., Chicago, 1945, pp. 7, 15,30. b): Drug Erup-
tions (Allergic and Nonallergic). Ibid., Chicago, 1946, p. 210.
'Dr. R. Keller and colleagues [Madison Foundation for Biochem. Research, New York
City] at our suggestion were kind enough to investigate the electrophysiologic properties
of Atabrine. We are indebted to these experienced investigators for the information that
the drug in aqueous solution showed the characteristics of an electropositive dye both in
vitro and in.biologic test objects (vital staining). However, relatively high concentrations
(0.3% and above) were necessary to attain these effects under the experimental conditions
employed
452 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
2. NISBET, Tn. W.: a): New cutaneous syndrome occurring in New Guinea and adjacent
islands. Preliminary report. Arch. Dermat. & Syph., 52: 22i, 1945. b): Dermatitis
due to quinacrine hydrochloride (atabrine). J. A. M. A. 134: 446, 1947.
3. LANGE, K., AND MATZNER, M. J.: The distribution of atabrine in the blood, the skin,
and its appendages. 3. of Lab. & Clin. Med. 31:742, 1946.
4. GINSBEiIG, J. E., AND SCHALLENBERGER, P. L.: Wood's light fluorescence phenomenon
in quinaerine medication. J. A. M. A. 131: 808, 1946.
5. KIEBLAND, R. R., SHEARD, Cn., MASON, H. L., AND L0BITz, W. C.: Fluorescence of
nails from quinacrine hydrochloride. J. A. M. A. 131: 809, 1946.
6. SULZBERGEE, MARION B.: a): Discussion to 8) (see below). b): Discussion to studies
of sweating. II. On the mechanism of action of local antiperspirants. Arch. Dermat.
& Syph. 60: 404, 1949.
7. a): LIvINGooD, CL. S., AND DIEMAIDE, F. R.: Evaluation of the untoward reactions
attributable to atabrine. J. A. M. A. 129: 1091, 1945. b): LIvIN000D, CL. S.: Derma-
tologic problems in the returning veteran. Pennsylv. Med. J. 50: 581, 1947.
8. SULZBERGER, MARION B., HEREMANN, F., Zx, F. G.: Studies of sweating. I. Prelimi-
nary report with particular emphasis on a sweat retention syndrome. J. Invest.
Dermat. 9:221, 1947.
9. SULZBERGEIZ, MARION B., HERRMANN, F., KELLER, R., AND PISHA, B. V.: Studies of
sweating. III. Experimental factors influencing the function of the sweat ducts. 3.
Invest. Dermat. 14: 91, Feb. 1950.
10. O'BRIEN, J. P.: The etiology of poral closure, an experimental study of miliaria rubra,
bullous impetigo and related diseases of the skin. J. Invest. Dermat. 15: 95, 1950.
11. MILBERG, D. L.: A new technic in photography with the use of ultraviolet rays. J.
Invest. Dermat. 15: 69, 1950.
